Noble Life Sciences is a contract research organization (CRO) owned and operated by scientists with decades of experience in drug development. In addition to offering standard services including in-vivo and in-vitro specialized models, Noble's team of scientists implements effective and efficient approaches to help guide your research and development programs.
Noble Life Sciences provides integrated preclinical services designed to accelerate drug development. Services include drug pharmacology, disease models, early safety assessments, biomarker validation and tumor profiling, cell line development, and analytical testing. We are committed to providing a strong scientific foundation to enable your preclinical decisions.
One of the biggest challenges in preclinical research is procuring high quality animal services to support your drug development mission. With a flexible and responsive approach to meeting your needs, Noble offers our clients the highest quality services backed by AAALAC accreditation, OLAW assurance, a USDA license and over 50 years of experience in animal housing and husbandry.
Noble Life Sciences Acquires Spring Valley Laboratories;Extends testing services to GLP, large animal and medical device studies
Noble Life Sciences Receives Maryland TEDCO Award for Development of ex vivo and in vivo Assays for Anti-Metastatic Drug Development